Invivodata Inc.

Seeking to improve on cumbersome, unreliable paper diaries for capturing patient experience data in pharmaceutical clinical trials, Invivodata is integrating Palm computing with a scientific, subject-centered approach to data collection that relies on repeated samplings to focus on the patient's current, immediate state in his or her natural environment.

Subjectivity matters in pharmaceutical clinical trials. Determining how a new drug makes a patient feel can be as important as measuring its physical effects, particularly for certain types of medications. Physical outcomes can be measured objectively by medical professionals, but a trial participant's own experience of the drug must be self-reported.

Handwritten patient diaries are the traditional vehicle for collecting this data, and they are universally viewed as problematic. Processing the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business

Second Quarter M&A Activity Looks Like More Of The Same, Mostly

 
• By 

The biopharma sector booked nearly the same number of acquisitions in each of the past two quarters, according to Evaluate data, but there are some encouraging signs in Q2.

Will AstraZeneca Reach Summit And Be A PD-1xVEGF Player?

 
• By 

Rumor mill suggests a $15bn licensing deal for ivonescimab is in the offing.

Eolo Pharma Advances In Obesity With Thermogenesis Approach

 
• By 

Emerging Company Profile: Early-stage biotech Eolo will seek cash and deals for its novel obesity drug SANA after positive Phase I results for weight loss, lean muscle mass preservation and fat mass reduction.